Table 4 Clinical characteristics of patients with PTAAB (n = 17)

Estimated blood loss (ml)

1740.00 ± 750.33

3762.50 ± 3728.33

0.096

Total transfusion (ml)

3130.00 ± 1159.52

6484.33 ± 4711.29

0.143

Red blood cell transfusion(u)

2.80 ± 2.68

10.66 ± 11.97

0.038#

Blood plasma transfusion (ml)

280.00 ± 268.32

1033.33 ± 1098.20

0.044#

Platelet transfusion(u)

0.00 ± 0.00

0.58 ± 1.16

0.289

Fibrinogen transfusion(g)

0.00 ± .0.00

2.04 ± 3.22

0.082

Prothrombin complex transfusion(u/100)

0.00 ± .0.00

4.00 ± 7.23

0.802

Postoperative hospital stay (day)

6.80 ± 2.95

8.25 ± 5.37

0.583

Preoperative hemoglobin(g/L)

116.80 ± 14.75

112.50 ± 13.77

0.594

Preoperative creatine (umol/L)

47.80 ± 3.19

53.08 ± 14.94

0.454

Preoperative urea nitrogen (mmol/L)

3.57 ± 1.33

3.36 ± 0.97

0.726

Postoperative hemoglobin at 24 h(g/L)

100.00 ± 25.52

99.17 ± 16.19

0.932

Postoperative creatine at 24 h (umol/L)

58.60 ± 24.37

59.25 ± 25.01

0.961

Postoperative urea nitrogen at 24 h (mmol/L)

3.07 ± 1.22

3.16 ± 1.54

0.912

Spinal anesthesia

2 (11.8%)

6 (50%)

0.080

Preoperative ureteral stent placement

5 (100%)

7 (58.3%)

0.245